SUSTAINABILITY REPORT 2013-15 
   
 
 
People
Safety
Quality
Availability
Environment
Community
Productivity
Engineering
Excellence
Continuous
Improvement
Annexures
 
Summary Report
 
 
CORPORATE GOVERNANCE
BOARD OF DIRECTORS
The Directors have expertise in the fields of strategy, management, finance, operations, science, technology, human resource development and economics.
The Board provides leadership, strategic guidance, objective and an independent view to the Company's management while discharging its fiduciary responsibilities, thereby ensuring that the management adheres to high standards of ethics, transparency and disclosure. The Board continuously reviews the Company's governance, risk and compliance framework, business plans and organisation structure to align with global standards and competitive benchmarks.
Whole-time Directors
 
As on March 31, 2015, the Board of
Dr. Reddy's consists of 10 Directors
Two Executive Directors, including the Chairman
Eight Independent Directors, including a woman Director, as defined under the Companies Act, 2013, SEBI's Clause 49 of the Listing Agreement and the Corporate Governance Guidelines of the NYSE Listed Company Manual
Independent Directors  
   
   
For further details about the Board and its functioning, please refer to page no. 54 of our Annual Report 2014-15.
 
Remuneration of Directors
The Company has a policy relating to the remuneration of Directors, Key Managerial Personnel (KMPs), Senior Management Personnel (SMPs) and other employees. The policy lays down remuneration principles and parameters to ensure that remuneration practices are competitive and reasonable, and in line with corporate and individual performance.
The Executive Directors are appointed by shareholders' resolution for a period of five years. No severance fee is payable to the Executive Directors. Excepting the commission payable, all other components of remuneration to the Executive Directors are fixed and in line with the Company's policies.
The remuneration for the Executive Directors, including the commission based on net profits of the Company, is recommended by the Nomination, Governance and Compensation Committee to the Board for consideration. The commission to be paid to the Executive Directors is decided by the Board every year, within the limits approved by the shareholders.
The Independent Directors are entitled to receive sitting fees and reimbursement of any expenses for attending meetings of the Board and its Committees, as well as commission based on the net profits of the Company.
For further details, please refer to page no. 57 of our Annual Report 2014-15.
 
   
 
 
Mr. Satish Reddy
Chairman
Mr. G. V. Prasad
Co-chairman, Managing Director & CEO
Dr. Omkar Goswami
Risk Management Committee
Mr. Ravi Bhoothalingam
Investment Committee, Corporate
Social Responsibility Committee,
Ombudsperson for the Whistle
Blower Policy
Mr. Anupam Puri
Governance, Corporate
Strategy and Lead
Independent Director
Dr. J. P. Moreau
Pharmaceutical
Regulatory Compliance
Dr. Bruce L. A. Carter
Science, Technology and
Operations Committee
Ms. Kalpana Morparia
Stakeholders' Relationship
Committee
Dr. Ashok S. Ganguly
Nomination, Governance &
Compensation Committee
Mr. Sridar Iyengar
Audit Committee, and all
financial and audit
matters that fall under the
remit of the Committee